Chronic Lymphocytic Leukemia Treatment Market Competitive Dashboard:Hoffmann-La Roche Ltd, AstraZeneca, and GlaxoSmithKline plc are few of the major players contributing to the development of the global chronic lymphocytic leukemia treatment market.Other players profiled in this MRFR report for presenting a detailed analysis of the market share are CELGENE CORPORATION, Teva Pharmaceutical Industries Ltd., Genmab A/S, Genentech, Inc., AbbVie Inc., Genzyme Corporation, Gilead, Johnson & Johnson Services, Inc., Novartis AG, ONO PHARMACEUTICAL CO., LTD., Inc., Ziopharm Oncology, Inc., and TG Therapeutics.Chronic Lymphocytic Leukemia Treatment Market Synopsis:Chronic Lymphocytic Leukemia (CLL) affects the blood and bone marrow.The diseases are chronic in the sense that it keeps on progressing gradually.The demand for effective treatments to control the diseases is expected to increase drastically in the years to come.Market Research Future (MRFR)’s observation unfolds that the global chronic lymphocytic leukemia treatment market was valued at USD 7.9 Bn in 2017 and is projected to mark a double-digit CAGR of 19% over the assessment period 2018 to 2023.Older adults are more prone to CLL, and their rising population is likely to intensify the need for efficient treatments over the next few years.This, in turn, is prognosticated to encourage massive investments in the chronic lymphocytic leukemia treatment market in the upcoming years, Thus, supporting market expansion.
Diagnostic Imaging Market Overview:The global diagnostic imaging market is witnessing increasing prospects that can guide the market towards a CAGR 6.2% and it would happen during the forecast period of 2018 to 2023, as per the latest published report by Market Research Future (MRFR).This report charts the course of the diagnostic imaging market and reveals possibilities in terms of factors and demography.Rising number of geriatric population, increasing registration of chronic disease patients, better technological inclusion, and others are expected to impact the market in the coming years.Governments are also ensuring a steady influx of investments that can trigger growth in research scopes that can impact better innovations.However, the machines are quite costly, which can be a growth-deterring factor in developing regions.In several cases, unfavorable reimbursement policies are distracting patients from availing such services, which can be a hurdle for the market.Diagnostic Imaging Market Segmentation:The global diagnostic imaging market, as it has been discussed in the MRFR report, includes product type, application, and end-user to ensure that the players get a proper scope to get themselves armed with the latest market dynamics and insights.By product type, the market for diagnostic imaging can be studied by having it segmented into ultrasound imaging systems, x-ray equipment, computed tomography (CT) scanners, magnetic resonance imaging (MRI), nuclear imaging systems, and other products.By application, the market for diagnostic imaging has been segmented into oncology, gynecology, cardiology, orthopedics, neurology, gastroenterology, and other applications.This is primarily due to the high investment capacity, which is allowing easy inclusion of these technologies and expansion of the research & development sector.
Functions that these pendants can perform include correct positioning of terminal units, delivery of medical gas & medicines, and specialty and electrical services.Over the last couple of years, the global medical pendant market size has continuously been rising with the increasing need for low-risk and safe workspace for the medical workforce.Moreover, the augmenting demand for medical pendant systems in operation theatres and intensive care units is escalating the market on the global platform.Considering the phenomenal upsurges, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global medical pendant market will garner a value of USD 149.01 MN by 2023 registering a 7% CAGR throughout the forecast period (2017-2023).Additional factors triggering the demand for medical pendants include the useful results achieved in the areas of surgery and endoscopy and technological advancements and innovations allowing medical systems to move on a press of a button.Global Medical Pendant Market – Regional AnalysisThe North American region heading with the presence of a large number of key players will retain its dominance over the global medical pendant market.Factors such as the presence of world-class healthcare infrastructure, superior healthcare practices, advanced facilities, and strict mandates from the regulating authorities drive the medical pendant market in the region.Also, increasing governmental support for the development of new pendants and R activities required for the same are some of the factors propelling the growth in the regional market.The region is a hub for technology and witnesses constant advancements which is a key reason why North America has improved access to technology that allows the region to have the upper hand in the market.Moreover, the availability to develop advanced technologies alongside the presence of well-established infrastructure that enables a suitable environment for the development as well as the early implementation of advanced technologies helps to increase the size of the market to an extent.The medical pendant market in the European region is another lucrative market, globally.The market is predominantly led by robust healthcare penetration and high per capita income in the region.Besides, additional factors such as the increased funding and the support from the public & private sectors for R activities and the resurging economy in the region that is playing a vital role in growing consumers purchasing power are providing impetus to the growth of the regional market.
Vascular Patches Market AnalysisGlobal vascular patches market growth is poised to touch USD 6.1 billion at a notable 4.1% CAGR over the predicted years (2018-2023).In every surgical procedure, the primary closure of sutures needs to be done effectively.Vascular patches are made from synthetic or biological materials and are characterized through excellent biocompatibility.On the contrary, scarcity of skilled professional, mishandling, decrease in carotid endarterectomy surgeries owing to low preference are factors that may restrict the growth of the vascular patches market.Vascular Patches Market SegmentationMRFR report provides an extensive segmental analysis of the vascular patches market on the basis of application, material and end-user.Based on material, it is segmented into synthetic vascular patches and biologic vascular patches.Of these, the biologic vascular patches will have the maximum share in the market over the predicted years followed by synthetic vascular patches that will grow at the fastest pace.Based on application, the vascular patches market is segmented into open repair of abdominal aortic aneurysms vascular bypass surgery and carotid endarterectomy.Of these, carotid endarterectomy will dominate the market followed by open repair of abdominal aortic aneurysms vascular bypass surgery which will grow at the fastest rate.Based on end-user, it is segmented into ambulatory surgical centers, hospitals and clinics and others.
Pain Relief Medication Market Overview: The global report on the pain relief medication market reveals the potentials to achieve 4.73% CAGR within a period of 2019 to 2025, which has been defined as the forecast period by Market Research Future (MRFR).The report contains factors like increasing expenditure capacity of the normal human beings, better inclusion in hospitals and various treatments, hike in research funding, better drug development technology using AI and other advanced technologies, hike in clearance rate, government support, and others that can ensure a rise in returns for the pain relief medication market.Their insights would help in developing tactical moves and enhance market profit.By drug class, the study on the pain relief medication market can be segmented into opioids, COX-2 inhibitors, nonsteroidal anti-inflammatory drugs, and others.France, Germany, the UK, Russia, Italy, and others are making substantial progress in the sector.The Asia Pacific region is getting acclaims as several regional companies from India, China, Japan, South Korea, and others are showing their keen interest in participating in the market.
Hepatitis C Drugs Market Competitive Analysis:Leading players in the global hepatitis C drugs market include Gilead Sciences Inc., Johnson & Johnson, GSK, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Novartis AG, Merck & Co. Inc., and AbbVie Inc.Hepatitis C Drugs Market AnalysisMarket Research Future (MRFR) has released a new report on the global hepatitis C drugs market .The report provides a complete overview of the market’s historical statistics and growth trajectory, in addition to elaborating on the market’s present statistics and providing detailed purojections regarding the market’s likely growth trajectory over the forecast period from 2016 to 2022.The global hepatitis C drugs market is expected to exhibit a steady 3.3% CAGR over the forecast period, rising from a valuation of USD 18.7 billion in 2015 to USD 22.7 billion by 2022.The slow CAGR of the global hepatitis C drugs market is due to the steady drop in the number of patients of hepatitis C in developed regions and the increasing prospects of the unorganized herbal medicine industry in emerging regions.Thanks to consistent healthcare advancement initiatives and awareness efforts, the prevalence of hepatitis C has fallen in developed countries over the years and could in fact dip into negatives over the coming years due to the widespread availability of medication and widespread awareness about the disease.The improving sanitation levels in developed countries have been vital for the drop in the prevalence of hepatitis C, as it has reduced the likelihood of the respective pathogens breeding in large amounts.The increasing awareness about hygiene and disease prevention in countries such as the U.S., Canada, the UK, France, and Germany is likely to further reduce the prevalence of hepatitis C over the coming years, restraining the growth of the hepatitis C drugs market in developed economies.In emerging regions such as Asia Pacific, hepatitis C is considerably prevalent.This is likely to be a major restraint for the hepatitis C drugs market over the forecast period.Hepatitis C Drugs Market Segmentation:The global hepatitis C drugs market is segmented on the basis of drug class, medicine system, route of administration, end user, and region.The global hepatitis C drugs market is segmented on the basis of drug class into anti-viral drugs, immuno-modulators, and others.On the basis of medicine system, the global hepatitis C drugs market is segmented into allopathic medicine, alternative medicine, and others.On the basis of route of administration, the hepatitis C drugs market is segmented into oral, injectable, and others.
Biologics Market AnalysisBiologics, also known as biopharmaceuticals are medicines that are extracted or semi-synthesized using biological sources including body cells of human, animals, and microorganisms through biotechnology.Moreover, the huge demand for biologics in the production of pharmaceuticals and vaccines is escalating the market on the global platform.Considering the exponential traction, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global biologics market will reach a valuation of USD 285,520.4 MN by 2023, registering a CAGR over 6.95% throughout the forecast period (2018-2023).Additional factors supporting the market to grow rapidly, include the growing incidences of chronic diseases and their diagnoses across the globe, increased availability of advanced diagnostic procedures, rising government initiatives in healthcare, and the growing technological advancements in research.Also factors such as the expansion of key producers and the investments they made in R for the incremental innovation and to sustain competition foster the market growth to an extent.On the other hand, factors such as the challenges occurred during the manufacturing of biologics are expected to impede the market growth over the forecast period.Global Biologics Market – SegmentsFor enhanced understanding, the report has been segmented into four key dynamics.By Product : Monoclonal Antibody, Interleukins, Vaccines, Growth Factors, and Gene Therapy among others.By Disease Indication : Rheumatoid Arthritis, Psoriasis/Psoriatic Arthritis, Cancer, and Diabetes among others.By Manufacturing : In-house and Out-sourcedBy Regions : Asia Pacific, North America, Europe, and the Rest-of-the-World.Global Biologics Market – Regional AnalysisThe North American region, heading with its well-developed healthcare sector accounts for the leading position in the global biologics market followed by the European and Asia Pacific region, respectively.The US, backed by the huge technological advancements in the field of manufacturing biologics leads the regional market.The European region owns the next largest share in the global biologics market, following the North American market closely.
Biomarker Tests Market InsightThe global biomarker test market is expected to exhibit a strong 14.5% CAGR over the forecast period from 2016 to 2022, according to the latest research report from Market Research Future (MRFR).According to the report, the global biomarker test market is expected to rise to a valuation of USD 16,112.8 million by 2022.Biomarker Tests Market Competitive Analysis:Leading players in the global biomarker test market include Quest Diagnostics, Medtronics, GE Healthcare, GSK plc, Pfizer Inc., Novartis AG, and F. Hoffman-La Roche AG.In August 2019, Genomind announced a new, improved biomarker test for mental health screening.Biomarker Tests Market Segmentation:The global biomarker test market is segmented on the basis of application, end use, and region.By application, the global biomarker test market is segmented into cancer, cardiovascular, infectious diseases, central nervous system conditions.Cancer is likely to dominate the global biomarker test market over the forecast period due to the increasing investment in cancer research and the increasing demand for more accurate diagnostic tests for specific cancers.The increasing precision afforded by biomarker testing in cancer diagnosis is likely to drive the cancer segment over the forecast period.Pharma and biotech companies are likely to retain the largest share in the global biomarker test market over the forecast period due to their growing investment in the sector.The pharma and biotech companies sector is expected to exhibit a steady rise to a valuation of USD 5,451.8 million by 2022.Biomarker Tests Market Regional Analysis:North America commands the largest share in the global biomarker test market and is likely to remain the leading revenue generator over the forecast period due to the growing demand for advanced, precise biomarker testing in the region.
AR & VR in Healthcare Market Competitive DashboardThe prominent players operating the global AR & VR in healthcare market are SURGICAL THEATER LLC, Atheer, 3D Systems Inc., Mindmaze, Microsoft, Hologic Inc., Firsthand Technology, Oculus VR, Osso VR Inc., Medical Realities, Psious, Augmedix, Google, Daqri, EchoPixel Inc., Orca Health Inc., and others.AR & VR in Healthcare Market ScenarioMarket Research Future asserts that the global AR & VR in the healthcare market is estimated to demonstrate 30.2% throughout the forecast period (2018-2023).Augmented reality (AR) is referred to as a technology which adds value to the real world by displaying real-time media and digital information.With the help of VR and AR, platform experts from several locations can join a surgical procedure virtually.AR and VR technology are not only beneficial for the doctors but also the patients and provide great convenience to the patients by allowing them to visit the physicians virtually.AR & VR in Healthcare Market Potential and PitfallsThe AR & VR technology is highly penetrating the healthcare market and is likely to transform the entire healthcare sector.For instance, the Digital Health Technology Catalyst program, in October 2018, granted USD 582,033 in order to collaborate between the Countess of Chester Hospital and University of Chester so that they can conjointly work on a VR project helping stroke patient practice.Moreover, rising convenience through virtual visits allows virtual reality to stay ahead in the healthcare AR VR market.On the contrary, concerns associated with data privacy, lack of competence in the deployment of AR and VR solutions, and lack of expertise among the medical practitioners are some of the top barriers considered to vitiate the market growth in the coming years.AR & VR in Healthcare Market: Segmental AnalysisThe global AR & VR in healthcare market has been segmented on the basis of offering, technology, application, device type, and end user.By mode of technology, the global AR & VR in healthcare market has been segmented into AR technology and VR technology.By mode of offering, the global AR & VR in healthcare market has been segmented into hardware components and software.By mode of device type, the global AR & VR in healthcare market has been segmented into AR device type and VR device type.By mode of application, the global AR & VR in healthcare market has been segmented into patient care management, fitness management, pharmacy management, surgery, medical training and education, and others.By mode of end-users, the global AR & VR in healthcare market has been segmented into surgical centers, hospitals & clinics, research and academic institutes, pharmaceutical companies, and others.AR & VR in Healthcare Market Regional InsightsGeographically, the AR & VR in healthcare market span across regions namely, Europe, Asia Pacific, America, and the Middle East & Africa.Among all the regions, the American region is considered to dominate the global AR & VR in healthcare market and is likely to retain its dominance in the coming years.
CAR T Cell Therapy Market Major PlayersKey players leading the global CAR T cell therapy market include Pfizer, Inc. (US), Novartis AG (Switzerland), Kite Pharma (US), Autolus Therapeutics PLC (UK), Cellectis (France), CARsgen Therapeutics (China), Sorrento Therapeutics (US), Juno Therapeutics (US), Legend Biotech (US), and Mustang Bio (US), among others.CAR T Cell Therapy Market AnalysisThe Chimeric Antigen Receptor (CAR) T cell therapy market is recognized as an effective treatment for hematologic cancer such as leukemia, lymphoma, and multiple myeloma.Increasing funding support from the governments as well as from the private entities for the R to develop and improve the CAR T cell technology predominantly drives the growth of the market.CAR T Cell Therapy Market – SegmentationMRFR has segmented the market into three main dynamics to widen the scope of understanding,By Target Antigen: CD19, CD22, and others.By Application : Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, and others.By Regions: Europe, Americas, Asia Pacific, Middle East & Africa, and Rest-of-the-World.Global CAR T Cell Therapy Market - Regional AnalysisNorth America is showing chances for retaining its dominance by holding the largest share in the global CAR T cell therapy market throughout the review period.Moreover, well-defined per capita healthcare expenditure and rising numbers of care facilities offering the therapy alongside the availability of advanced devices contribute to the growth of the regional market.The US, backed by its vast advancements in CAR T cell therapy industry, is expected to hold the largest share in the regional as well as in the global market.Besides, the availability of technologically advanced devices and the proliferating healthcare sector in the region drive the growth of the market.Also, increasing healthcare expenditures and increasing R activities in biotechnology led by the improving economy and the government support in the region contribute to the market growth.
Medical carts are equipment used by nurses for ferrying medical equipment to patient rooms.They are used in storing medicines, syringes, and other medical accessories required for the treatment of small cuts, abrasions, etc.Market Research Future (MRFR) has focused on drivers, trends, opportunities, and challenges faced by market players and its latent potential by segmenting the global medical carts market report by product type, type, material type, end-user, and region.Medical Carts Market OutlookThe global medical carts market is poised to touch a high valuation by exhibiting 12.1% CAGR from 2018 to 2023 (forecast period).The large patient inflow in hospitals and medical centers can also contribute to the market growth.The need for medical carts in medical universities and colleges for internships can bode well for the market.Availability of such equipment via ecommerce stores and retail stores is likely to push the market revenue to a higher degree.Rising use of mobile carts which assist nurses in patient care and alleviate the burden in a deadline-driven environment can drive the market.
Healthcare Cloud Computing Market Synopsis:Market Research Future (MRFR) has published a report stating that the global healthcare cloud computing market is marked to expand at a remarkable growth rate in the upcoming years.Increased adoption of internet of things (IoT) in the healthcare sector of developed and developing regions are leading to the increased reliance on cloud-based services in the healthcare sector.Rise in demand for cloud-based platform to manage a large amount of unstructured data in the healthcare sector is majorly propelling the growth of the global healthcare cloud computing market.Based on applications, the global healthcare cloud computing market has been segmented into non-clinical information system (NCIS) and clinical information system (CIS).The North America region commands the major share in the global healthcare cloud computing market owing to the presence of well-developed healthcare sector, rapid adoption of cloud-based solutions, constant technological advancement and high concentration of developed economies that are expanding their funding for advancement of healthcare services in this region.The Asia Pacific region is expanding significantly in the global healthcare cloud computing market owing to the rapid development of healthcare sector in the emerging economies, rise in awareness regarding the benefits of cloud-based services, and emergence for sophisticated platform to maintain the large amount of healthcare data that is present in an unstructured manner in this region.
Monoclonal Antibody Therapy Market AnalysisMonoclonal antibodies are laboratory-produced antibodies that are whose purpose is to serve as the substitute of natural antibodies that can enhance or repeat the immune system's attack on harmful cells.Market Research Future (MRFR) has published and released a research report about the global monoclonal antibody therapy market that estimates boost for this Global Monoclonal Antibody Therapy Market size at 10.5% CAGR (Compound Average Growth Rate) between 2016 and 2022.In terms of market value, the worth of global monoclonal antibody therapy market has been estimated to be the US $ 140 bn by the end of the forecast period.Analyzing the market structure, this report offers insights about factors affecting the market growth.Estimating the market size and forecasting the revenue, this reports covers and observes the competitive developments of market players that include mergers and acquisitions, joint ventures, new product developments, research and developments (R), and strategic alliances.The major factors strengthening the growth of the global monoclonal antibody therapy market are rising health awareness, an unhealthy lifestyle lowering the immunity of consumers and increasing spending on healthcare.The global monoclonal antibody therapy market has been segmented on the basis of application, end user, source, and lastly, region.The application-based segmentation segments this market into analytical & chemical uses, autoimmune diseases, cancer treatment, diagnostic test, hematological disorders, and others.Regarding source, the market has been segmented into chimeric, human, humanized, recombinant, and other.Depending on geographic region, monoclonal antibody therapy market is segmented into four key regions: America, Europe, Asia-Pacific, and Middle East & Africa.
Immunoprecipitation Market OutlookThe global immunoprecipitation market is expected to exhibit a solid 5.2% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).Immunoprecipitation is becoming increasingly important in the life sciences sector, leading to a growing demand for immunoprecipitation processes and objects.The report presents a detailed overview of the global immunoprecipitation market, including a historical review of the market’s growth trajectory, a detailed analysis of the market’s major drivers and restraints, and forecasts regarding the market’s growth potential over the forecast period from 2018 to 2023.The growing demand for antigen detection processes, due to their high utility in autoimmune disorders, is the major driver for the global immunoprecipitation market.Immunoprecipitation uses magnetic particles or agarose resin to isolate specific antigens from a mixture of antigens, i.e.The rising demand for personalized therapeutics is also likely to be a major driver for the global immunoprecipitation market over the forecast period.Immunoprecipitation Market Competitive Leaderboard:Leading players in the global immunoprecipitation market include Abcam plc, GenScript, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Merck KGaA, BioLegend Inc., Takara Bio Inc., Rockland Immunochemicals Inc., Cell Signaling Technology Inc., and Geno Technology Inc.Immunoprecipitation Market Segmentation:The global immunoprecipitation market has been segmented on the basis of type, product, end user, and region.The immunoprecipitation market, on the basis of type, has been segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, and RNA immunoprecipitation.The market, by product type, has been segmented into kit, reagent, and others.
Feminine hygiene products, simply put, are products utilized by women for maintaining their personal hygiene such as feminine hygiene wash, menstrual cups, panty liners, tampons, and sanitary napkins/pads.The wide variety of products accessible, including both external and internal feminine products along with their size and comfort, have helped in facilitating the rising independence of females as well as their ability to be active all throughout the month.Various factors are adding to the global feminine hygiene market growth.According to the new MRFR report, such factors include surging demand for panty liners and tampons in developing countries, growing awareness about female health & hygiene, availability of low-cost feminine hygiene products, and the middle-class population's increasing disposable income in China and Brazil.On the contrary, the presence of toxic chemicals in the feminine products, coupled with increasing cases of allergy among women, are factors that may limit the global feminine hygiene market growth over the forecast period.Feminine Hygiene Market Segmentation The MRFR report offers an inclusive segmental analysis of the global feminine hygiene market report based on distribution channel and product type.The increasing adoption rate of sanitary napkins/pads across the world is adding to the growth of the segment.
Radiology Services Market OverviewGlobal radiology services market is growing dramatically, mainly due to the advances in radiology technologies.Rising usages of radiology services such as X-Rays, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, fusion imaging, and nuclear medicine, to offer accurate diagnosis are fostering the growth of the market.Moreover, rising R investments and strategies adopted by the top players operating in the market are contributing to the market growth, bringing about innovations and new product launches.Increasing efforts of regulatory agencies to reduce the regulatory burden on the medical device industry is further supporting the market growth excellently.Moreover, government initiatives to promote radiology technology as the best option for early diagnosis in the multitude of chronic daises propel the growth of the market.On the other hand, risks associated with high radiation exposure could hamper market growth during the assessment period.Nevertheless, the availability of advanced radiology technologies would support the market growth throughout the review period, providing ample scope of the growth opportunities.Radiology Services Market – SegmentsThe analysis is segmented into five main dynamics to widen the scope of understanding,By Product Type : Stationary Digital Radiology Systems (stationary ceiling-mounted and floor-to-ceiling mounted system) and Portable Digital Radiology Systems.By Application : Chest Imaging, Cardiovascular Imaging, Dental Imaging, Orthopedic Imaging, Mammography Imaging, and others.By Technology : Computed Radiology, Direct Digital Radiology, and others.By End User : Hospitals, Diagnostic Centers, and others.By Regions : Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-WorldBased on the product type, the market is segmented into stationary digital and portable digital radiology systems.
Endodontic Devices Market InsightsAccording to the report published by Market Research Future, the global endodontic devices market is reckoned to register a compound annual growth rate of 5.34% over the forecast period of 2018–2023.The central soft pulp of a tooth comprised of blood vessels and nerves, when infected cause sensation of heat and pain, and swelling, hence, create discomfort.The urge to maintain the dental setup owing to aesthetic purpose is increasing the adoption of root canal among people.MRFR identifies these as factors expected to cast a positive impact on the global endodontic market growth.The instruments segment has been narrowed down to apex locators, endodontic scalers, machine-assisted obturation systems, handpieces, and endodontic lasers.Based on region, the endodontic devices market study has been performed across North America, Latin America, Asia Pacific, Europe, and the Middle East Asia and Africa.The Asia Pacific endodontic devices market is expected to be the fastest growing in the coming years.
Enteral Feeding Devices Market OverviewAs per Market Research Future (MRFR) analysis, the global enteral feeding devices market held a valuation of USD 2,302.4 million in 2017.It is estimated to grow at a CAGR of 6.1% from 2017 to 2023 (forecast period).Enteral feeding is a nutritional therapy process where nutrients are supplied directly to the gastrointestinal tract (GIT).Enteral feeding devices help deliver medications and nutrients directly to the stomach, duodenum, or jejunum via either the nose, mouth or direct percutaneous route.For example, the World Health Organization (WHO) stated that the global elderly population was 841.0 million in 2013, 962.3 million in 2017, and expected to reach more than 2.0 billion by 2050.On the other hand, complications associated with enteral feeding devices, including inadvertent dislodgement of tubes and strict refund policies, are expected to hinder market growth over the forecast period.The nasoenteric feeding tubes segment is further categorized into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes.Based on end-user, the global enteral feeding devices market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs).Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828 Enteral Feeding Devices Market Regional AnalysisRegion-wise, the global enteral feeding devices market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.The Americas led the global market for enteral feed devices in 2017.
Light Therapy Market OverviewGlobal light therapy market is growing at a rapid pace, mainly due to the rising demand for non-invasive treatments.Applications of light therapy are increasing widely, comprising treatments of a myriad of diseases ranging from sun damage and acne to mTBT and skin cancer.Global Light Therapy Market - SegmentationThe analysis has been segmented into five major dynamics.By Product: Light Box, Floor & Desk Lamps, Light Visor, Handheld Devices for Skin Treatment (HDST), Dawn Simulator, Light Therapy Bulbs, and others.By Application: Psoriasis, Vitiligo, Eczema, Acne Vulgaris, Seasonal Affective Disorder (SAD), Sleeping Disorders, and others.By Light Type: Blue Light, Red Light, White Light, and others.By End-User: Homecare Settings, Dermatology Clinics, and others.By Regions: Europe, Americas, Asia Pacific, Middle East & Africa, and Rest-of-the-World.Also, the blue light exposure therapy is useful in healing people with mild traumatic brain injury, sleep disorders (insomnia).Red Light: The red light therapy (RLT) is majorly used in joint pain and arthritis treatment.There are a whole lot of studies going on to find if RLT can be effective in treating muscle atrophy, slow wound healing, and bone density issues caused by weightlessness during space travel.White Light: Bright/ white light therapy improves mood & energy by triggering the release of serotonin.It also improves sleep & focus by resetting circadian rhythm to its natural state & regulating melatonin.
Neonatal Intensive Care Market OverviewMarket Research Future (MRFR) predicts that the global neonatal intensive care market share is projected to register a considerable compound annual growth rate of approximately 5.5% during the forecast period of 2018–2023.The neonatal intensive care is a specialized unit that takes intense care of premature neonates.The surge in premature neonate natality rate is one of the major causes identified to boost the neonatal intensive care market growth.Technical advancement are aiding in the development of smart incubators that protect the neonates from extreme conditions like noise, temperature, infection, and helps in providing oxygen, medicine, and most importantly protection.The neonatal intensive care market study has been segmented into product and end user.On the basis of product, the market has been segmented into phototherapy equipment, catheters, convertible warmer and incubators, incubators, respiratory devices, infant warmers, neonatal monitoring devices, and others.Neonatal Intensive Care Market Regional InsightsThe demographic insights into the neonatal monitoring devices market give a holistic overview of the regional progress of the market.In November 2018, the Centers for Disease Control and Prevention (CDC) reported that about 40,000 births per year in the US are born with congenital heart defects (CHDs).